Charles River provides a number of different, adaptable animal models for the assessment of agents designed to treat diabetes and obesity. Our ability to provide the appropriate combination of species/strain, agonist and selected analyses of various metabolic indicators allows our clients the flexibility they need to demonstrate therapeutic efficacy for their test agents.